PhotoMedex (NASDAQ: PHMD) and Zeltiq Aesthetics (NASDAQ:ZLTQ) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitabiliy, valuation, risk, earnings, analyst recommendations, dividends and institutional ownership.

Risk & Volatility

PhotoMedex has a beta of 0.74, suggesting that its share price is 26% less volatile than the S&P 500. Comparatively, Zeltiq Aesthetics has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500.

Earnings & Valuation

This table compares PhotoMedex and Zeltiq Aesthetics’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
PhotoMedex $30.70 million 0.10 -$1.42 million N/A N/A
Zeltiq Aesthetics N/A N/A N/A $0.74 76.32

Zeltiq Aesthetics has higher revenue, but lower earnings than PhotoMedex.

Insider & Institutional Ownership

5.2% of PhotoMedex shares are held by institutional investors. 22.4% of PhotoMedex shares are held by insiders. Comparatively, 15.6% of Zeltiq Aesthetics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares PhotoMedex and Zeltiq Aesthetics’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
PhotoMedex -52.25% N/A -45.55%
Zeltiq Aesthetics 9.78% 31.74% 20.11%

Analyst Ratings

This is a breakdown of current recommendations and price targets for PhotoMedex and Zeltiq Aesthetics, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PhotoMedex 0 0 0 0 N/A
Zeltiq Aesthetics 0 9 2 0 2.18

Zeltiq Aesthetics has a consensus target price of $49.21, indicating a potential downside of 12.86%. Given Zeltiq Aesthetics’ higher possible upside, analysts clearly believe Zeltiq Aesthetics is more favorable than PhotoMedex.

Summary

Zeltiq Aesthetics beats PhotoMedex on 6 of the 9 factors compared between the two stocks.

About PhotoMedex

PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.

About Zeltiq Aesthetics

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians. It also offers consumables, which are CoolSculpting procedure packs that are needed to perform procedures using its CoolSculpting system. CoolSculpting is a non-invasive fat reduction procedure. CoolSculpting utilizes its controlled cooling technology to selectively reduce stubborn fat bulges. The CoolSculpting system includes CoolSculpting control unit and CoolSculpting applicators. The CoolSculpting Applicator delivers vacuum suction and cooling to the fat bulge being treated.

Receive News & Ratings for PhotoMedex Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PhotoMedex Inc and related companies with MarketBeat.com's FREE daily email newsletter.